ArticleACR open rheumatology2026

Long-Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus Erythematosus.

Edward M Vital et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.